SCHEMBL576763

SCHEMBL576763

COC(=O)C(CN1C(O)c2ccccc2C1O)c1ccc2cc(OC)ccc2c1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 7/20 0.50
AKR1C2 P52895 7/20 0.50
PTGS1 P23219 3/20 0.50
AKR1C1 Q04828 1/20 0.50
PTGS2 P35354 5/20 0.47
TSHR P16473 2/20 0.47
CDC42 P60953 1/20 0.47
RAC1 P63000 1/20 0.47
CYP1A2 P05177 1/20 0.47
SLC22A6 Q4U2R8 1/20 0.47
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ALOX5 P09917 1/20 0.43
LMNA P02545 1/20 0.42
MAPT P10636 1/20 0.42
CYP2C9 P11712 1/20 0.42
ABCB11 O95342 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL577062 0.80 AKR1C3 (0.42) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL11155116 0.77 AKR1C3 (0.76) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL576750 0.77 PTGS2 (0.56) PTGS1PTGS2CYP1A2SLC22A6LMNA
SCHEMBL8811015 0.76 AKR1C3 (0.61) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL11157275 0.75 AKR1C3 (0.63) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL577330 0.74 PTGS2 (0.56) AKR1C3AKR1C2PTGS1PTGS2TSHR
SCHEMBL19776632 0.71 AKR1C3 (0.58) AKR1C3AKR1C2PTGS1AKR1C1PTGS2
SCHEMBL5829437 0.70 SLC6A3 (0.48) AKR1C3AKR1C2PTGS1AKR1C1
SCHEMBL31170906 0.70 SLC6A3 (0.48) AKR1C3AKR1C2PTGS1AKR1C1
SCHEMBL505811 0.70 TDP1 (0.77) AKR1C3AKR1C2PTGS1PTGS2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2418200-A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF- MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES EMS S. A. (BR) 2012-02-15 EP claimed